The Response of New GA Therapies From Patients, Payers | ASRS 2023

What are GI protective therapies and how might they help?Подробнее

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MDПодробнее

GI CONNECT Update from ASCO 2024Подробнее

ASCO 2023 Promising Results in Breast Cancer From NATALEE and PHERGainПодробнее

New sensitivities after patient takes LRA TestПодробнее

4 Reasons to Attend the 2024 HPS Alliance Hospice WorkshopПодробнее

Updates in colorectal and rectal cancer at ASCO GI 2023Подробнее

Retina Dilating Eye DropsПодробнее

Patient Involvement in #HealthTechnologyAssessment - GAAPP Academy 2023Подробнее

Georgia rehab clinic submitted hundreds of false claims, judge saysПодробнее

Medical Gaslighting Is Real!Подробнее

Predicting cancer patient response to PARP inhibitorsПодробнее

Report Back from ASCO 2023: What’s the Latest News in Metastatic Breast Cancer?Подробнее

The Game Changer: Alphonso’s story Part 3Подробнее

New Insight: A Changing Landscape of Retinal Therapeutics with Charles Wykoff, MD, PhDПодробнее

Payer EMR access: How to ensure health systems see equal gains in efficiency + outcomesПодробнее

Updates Influencing Standard of Care from ASCO GI: 2023 Review and Renew Lake TahoeПодробнее

PARP Inhibitors in Prostate Cancer Treatment - Program: Patient Education Ambassadors 2023-24Подробнее

Key clinical trial updates from ASCO GI 2023Подробнее